title: Danazol therapy: an unusual aetiology of hepatocellular carcinoma.
authors.forename: D
authors.initials: D
authors.lastname: Crampon
authors.forename: R
authors.initials: R
authors.lastname: Barnoud
authors.forename: M
authors.initials: M
authors.lastname: Durand
authors.forename: D
authors.initials: D
authors.lastname: Ponard
authors.forename: C
authors.initials: C
authors.lastname: Jacquot
authors.forename: J J
authors.initials: JJ
authors.lastname: Sotto
authors.forename: C
authors.initials: C
authors.lastname: Letoublon
authors.forename: J P
authors.initials: JP
authors.lastname: Zarski
mesh_terms: D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced*; D003613:Danazol / Q000009:adverse effects*; D004965:Estrogen Antagonists / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000139:chemically induced*
chemical_list: D004965:Estrogen Antagonists; D003613:Danazol